EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

New Antibiotics Against Multidrug-Resistant Gram-Negative Bacteria in Liver Transplantation: Clinical Perspectives, Toxicity, and PK/PD Properties

Andrea Lombardi, Laura Alagna, Emanuele Palomba, Giulia Viero, Anna Tonizzo, Davide Mangioni, Alessandra Bandera

Transplant International · 2024

DOI: 10.3389/ti.2024.11692 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Transplant International, 2024. Verfasst von Andrea Lombardi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology and Transplantation, University of Milano, Milan, Italy. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Liver Transplantation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance is a growing global health problem, and it is especially relevant among liver transplant recipients where infections, particularly when caused by microorganisms with a difficult-to-treat profile, are a significant cause of morbidity and mortality. We provide here a complete dissection of the antibiotics active against multidrug-resistant Gram-negative bacteria approved over the last years, focusing on their activity spectrum, toxicity profile and PK/PD properties, including therapeutic drug monitoring, in the setting of liver transplantation. Specifically, the following drugs are presented: ceftolozane/tazobactam, ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam, cefiderocol, and eravacycline. Overall, studies on the safety and optimal employment of these drugs in liver transplant recipients are limited and especially needed. Nevertheless, these pharmaceuticals have undeniably enhanced therapeutic options for infected liver transplant recipients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsLiver TransplantationHumansbeta-Lactamase InhibitorsDrug Resistance, Multiple, BacterialGram-Negative Bacteria

Stichwörter der Autor:innen

BL/BLIantimicrobial stewardshipliver transplantationmetallo-beta lactamasesmultidrug-resistant microorganisms

Substanzen

Anti-Bacterial Agentsbeta-Lactamase Inhibitors

Autor:innen und Institutionen

  • Department of Pathophysiology and Transplantation, University of Milano, Milan, Italy.
  • Infectious Diseases Unit, IRCCS Ca' Granda Ospedale Maggiore Policlinico Foundation, Milan, Italy.

Zitieren

APA

Lombardi, A., Alagna, L., Palomba, E., Viero, G., Tonizzo, A., Mangioni, D., & Bandera, A. (2024). New Antibiotics Against Multidrug-Resistant Gram-Negative Bacteria in Liver Transplantation: Clinical Perspectives, Toxicity, and PK/PD Properties. Transplant International. https://doi.org/10.3389/ti.2024.11692

Vancouver

Lombardi A, Alagna L, Palomba E, Viero G, Tonizzo A, Mangioni D, et al. New Antibiotics Against Multidrug-Resistant Gram-Negative Bacteria in Liver Transplantation: Clinical Perspectives, Toxicity, and PK/PD Properties. Transplant International. 2024. doi:10.3389/ti.2024.11692

BibTeX
@article{Lombardi2024,
  author = {Lombardi, Andrea and Alagna, Laura and Palomba, Emanuele and Viero, Giulia and Tonizzo, Anna and Mangioni, Davide and Bandera, Alessandra},
  title = {New Antibiotics Against Multidrug-Resistant Gram-Negative Bacteria in Liver Transplantation: Clinical Perspectives, Toxicity, and PK/PD Properties},
  journal = {Transplant International},
  year = {2024},
  doi = {10.3389/ti.2024.11692}
}
Kostenlos starten →